Matthew Head
CFO @Onconano Medicine, Inc
Signup · Get unlimited contacts
WORK HISTORY
CFO @Onconano Medicine, Inc
OncoNano Medicine is developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease. pH variability is a proven, simple and effective identifier of diseased tissue providing a foundation for the development of highly targeted therapeutics and imaging agents. The product candidates in the company\'s pipeline are focused on cancer treatments and immunotherapy, with ONM-100 for intraoperative imaging currently in Phase 1.
EDUCATION
TCU Neeley School of Business
MBA, Finance
The University of the South
BS, Economics
SKILLS
ABOUT MATTHEW HEAD
Business-facing Finance Leader with the ability to draw on a broad experience across a…
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.